Judge Blocks Rival Botox Drug In Trade Secrets Trial
A California federal judge on Tuesday barred Merz Pharmaceuticals LLC from selling wrinkle-reducing drug Xeomin, just days before the Botox competitor's nationwide launch, in a bench trial over allegations the company's...To view the full article, register now.
Already a subscriber? Click here to view full article